Stay updated on Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedNumerous new study sites were added across the US and worldwide and several existing sites were removed, changing where participants can enroll.SummaryDifference3%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check32 days agoChange DetectedBanner announcing a government funding lapse was removed from the page; core study details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedThe new screenshot shows minor UI/formatting changes to the Study Details page; core data and criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check83 days agoChange DetectedVersion update from v3.0.2 to v3.1.0; no substantive content changes identified.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.